Oxygen Indicator for Medical Containers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical containers face challenges such as incompatibility of medical solutions during long-term storage, contamination risks from compounding, and the inability of existing oxygen indicators to withstand heat sterilization and maintain color distinction over time.

Innovation Solution

A flexible multi-chamber container with peel seals and an oxygen indicator comprising indigo carmine, a buffer, microcrystalline cellulose, and a reducing agent, which remains color-distinguishable after autoclaving and prolonged storage, and an oxygen permeable packet to detect oxygen exposure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing oxygen indicators are used in medical containers, then oxygen detection function is provided, but the indicators cannot withstand heat sterilization and maintain color distinction over time

Engineering Contradiction:
Improveoxygen detection reliabilityVSAvoidstorage stability
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent modifies the chemical parameters of the oxygen indicator system by selecting specific components (indigo carmine as indicator, glucose as reducing agent, pH buffer) and optimizing their concentrations to achieve both heat sterilization resistance and long-term storage stability while maintaining color distinction

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite oxygen indicator system combining multiple substances (indigo carmine, glucose, pH buffer, and other stabilizing agents) that work together to provide heat resistance, storage stability, and reliable oxygen detection functionality simultaneously

Inventive Principle:
Principle #40Composite materials

2Productivity

If multiple medical solutions are stored together in a single container, then storage efficiency is improved, but incompatibility between solutions causes contamination and formulation errors

Engineering Contradiction:
Improvestorage efficiencyVSAvoidsolution incompatibility
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent divides the storage container into multiple separate chambers, each capable of holding different medical solutions independently. This segmentation prevents direct contact between incompatible solutions while maintaining storage efficiency, allowing solutions to be mixed only when needed through controlled interfaces between chambers

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If manual compounding of medical solutions is performed, then flexibility in formulation is achieved, but time consumption and contamination risks increase

Engineering Contradiction:
Improveformulation flexibilityVSAvoidcompounding time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The patent prepares multiple medical solutions in advance and stores them in separate chambers within the same container. This preliminary action eliminates the need for time-consuming manual compounding at the point of use, as solutions are already prepared and simply need to be mixed through controlled interaction between chambers

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution allows for safe storage and mixing of medical solutions, reduces contamination risks, and provides a reliable indication of oxygen exposure, ensuring the integrity and safety of medical formulations.

Implementation Method 1

The oxygen indicator comprises: a) greater than 6 and less than 60 g/L of indigo carmine; b) a buffer to adjust the pH to a range of about 9.0 to about 9.75; c) from 150 g/L to 210 g/L of microcrystalline cellulose; d) a reducing agent

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Data Source

PatentEP1909736B1Oxygen indicator for use in medical products and packet containing oxygen indicator
Publication Date: 2014.11.12 BAXTER INT INC
  • EP1909736B1 patent drawingFigure 1~2
  • EP1909736B1 patent drawingFigure 3~4
  • EP1909736B1 patent drawingFigure 5

AI summary

An oxygen indicator is provided for revealing the presence of oxygen in a container housing a medical formulation. The indicator can be formulated with components deemed safe for use with medical products. A preferred oxygen indicator can withstand heat sterilization and prolonged storage and can provide a distinct and marked color change to indicate oxygen is present. Preferably, the indicator can be manufactured in its oxidized form and reduced upon steam sterilization. Additionally, both the color of the reduced form and the color of the oxidized form should not fade or significantly change during storage. Moreover, once a color change has occurred indicating the presence of oxygen, the oxidized color preferably remains substantially unchanged visually to the observer even after prolonged storage. The oxygen indicator can be housed in a polymeric pouch or packet having a transparent portion for viewing the color of the indicator.